Eurosurveillance, Volume 10, Issue 8, 24 February 2005
Table of Contents
Between 31 January and 4 February 2005, over 21 000 people in the city of Zeist in the Netherlands were tested for latent tuberculosis infection or active tuberculosis after possible exposure via a supermarket employee.
A single case of infection with a highly drug-resistant strain of HIV that progressed rapidly has been diagnosed in a New York City resident who had not previously undergone antiviral drug treatment
Infections due to ß-lactam resistant E. coli strains that produce extended-spectrum ß-lactamases (ESBL) of the CTX-M family are emerging in European countries such as the United Kingdom and Spain
A recently published report describes the case of a 4 year old boy who presented with fever, headache, vomiting and severe diarrhoea, followed by seizures and coma (gastroenteritis and encephalitis) in Vietnam in February 2004
There is increasing recognition that antibiotic consumption provides a major selective pressure for the emergence and persistence of antibiotic-resistant strains of bacteria. In 2001, a European Union Council Recommendation stated that data should be gathered on antibiotic use and antimicrobial resistance in European countries
On 16 February 2005, the Deutsche Stiftung Organtransplantation (German Foundation for Organ Transplantation, http://www.dso.de/) announced possible rabies cases in three of six patients who received organs from a donor who died in late December 2004
Eurosurveillance Weekly Release: 24 February 2005
The opinions expressed by authors contributing to Eurosurveillance
do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance
site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence
. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Eurosurveillance [ISSN] - ©2007-2016. All rights reserved